-
Dr. Owen O’Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly | The 8th Hematologic Oncology
In order to further improve the diagnostic and treatment level of leukemia and lymphoma in China, “The 8th Hematologic Oncology Academic Conference of CSCO,” co-hosted by the Chinese Society of Clinical Oncology (CSCO), the Leukemia Expert Committee of CSCO, and the Lymphoma Expert Committee, and co-organized by the Harbin Hematological Tumor Research Institute and Peking…
-
EHA Global Perspectives | Dr. Edward Laane: Advancing Breakthroughs in MM Treatment and PRO Standardization
Multiple myeloma (MM) has long been a focus of hematology research due to its complex nature and the challenges it presents in treatment. As treatment methods continue to advance and new drugs emerge, patient survival rates and quality of life are receiving unprecedented attention. In this context, the accurate measurement of patient-reported outcomes (PROs) becomes…
-
Dr. Dong Ji: Exploring Liver Fibrosis Reversal and Personalized Treatment
The liver is a powerful organ with complex physiological structures and functions. Liver fibrosis is a dynamic pathological process associated with various chronic liver diseases, ultimately leading to cirrhosis. In cirrhosis, the liver not only becomes harder but also shrinks in size, with imaging showing changes in the liver’s appearance accompanied by alterations in hepatic…
-
Dr. Hui Wang: PURPOSE 1 Study Reveals Outstanding Efficacy of Long-Acting Injectable Lenacapavir in Preventing HIV Infection in Women
On July 24th, during the highly anticipated Co-Chairs’ Choice session at the 25th International AIDS Conference in Munich, Germany, the PURPOSE 1 study was unveiled, highlighting a significant breakthrough in HIV prevention. The study demonstrated the exceptional efficacy of the long-acting injectable drug Lenacapavir in preventing HIV infection among women. The study was simultaneously published…
-
SIFIC 2024 | Dr. Fan Wu: Challenges and Control of Candida auris and Babesiosis
The 20th Shanghai International Forum for Infection Control (SIFIC) and the 8th Oriental Forum on Complex Infectious Diseases (OFCID), jointly held with the Global Chinese Society of Clinical Microbiology and Infectious Diseases (GCSCMID) Annual Meeting, successfully took place at the Shanghai International Convention Center from July 25-27, 2024. During the event, Dr. Fan Wu from…
-
News Express | Belzutifan, an Oral HIF-2α Inhibitor, for Treating VHL-Associated Congenital Polycythemia
The “News Express” column aims to bridge the gap between cutting-edge research and clinical practice, enabling hematology enthusiasts and professionals to quickly grasp industry trends, spark innovative thinking, and broaden their professional horizons. Hematology News carefully curates the latest hematological research findings from top global journals. Each selected article represents a fusion of science and…
-
Dr. Bing Xu: Understanding and Conquering IVLBCL—Progress in Diagnosis and Treatment | 2024 Northern Hematology and Oncology Immunotherapy Conference
Intravascular large B-cell lymphoma (IVLBCL) is a rare form of non-Hodgkin lymphoma with atypical clinical presentations, leading to high rates of misdiagnosis and missed diagnosis in clinical practice. There is an urgent need to improve the current status of diagnosis and treatment. Recently, the “2024 Northern Hematology and Oncology Immunotherapy Conference,” hosted by the Tianjin…
-
Dr. Jun Shi: Ongoing Exploration to Optimize First-Line Treatment for Non-Gastric MALT Lymphoma | 2024 Northern Hematology and Oncology Immunotherapy
While radiotherapy is the recommended first-line treatment for mucosa-associated lymphoid tissue (MALT) lymphoma, for certain non-gastric MALT lymphomas in specific locations, radiotherapy may result in significant side effects that can affect patients’ quality of life. Recently, the “2024 Northern Hematology and Oncology Immunotherapy Conference,” hosted by the Tianjin Society of Hematology and Regenerative Medicine, was…
Connecting Medical Expertise through Media